Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Stip

Showing results (251-260 of 278) with videos related to

Pageof 28
Sort By:
Neuroimage|August 5, 2015
Impact of the resolution of brain parcels on connectome-wide association studies in fMRIPierre Bellec, Yassine Benhajali, Felix Carbonell, et al.
Current Medical Research and Opinion|July 13, 2006
Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trialStéphane Potvin, Emmanuel Stip, Olivier Lipp, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|October 25, 2022
Frequency of illness anxiety (hypochondriasis) by proxy encountered by doctors in parents towards their childrenDina Aly El-Gabry, Karim Abdel Aziz, Maitha Hasan Al-Hosani, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 2020
Chronic Neuroleptic-Induced Parkinsonism Examined With Positron Emission TomographyManon Galoppin, Pierre Berroir, Jean-Paul Soucy, et al.
Journal of Psychopharmacology (Oxford, England)|March 1, 2008
Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapyStéphane Potvin, Edouard Kouassi, Olivier Lipp, et al.
Journal of Clinical Psychopharmacology|August 16, 2003
A Canadian multicenter trial assessing memory and executive functions in patients with schizophrenia spectrum disorders treated with olanzapineEmmanuel Stip, Gary J Remington, Serdar M Dursun, et al.
Pharmacology, Biochemistry, and Behavior|April 3, 2022
Cannabidiol effects on cognition in individuals with cocaine use disorder: Exploratory results from a randomized controlled trialElie Rizkallah, Violaine Mongeau-Pérusse, Léonardo Lamanuzzi, et al.
BMC Psychiatry|May 4, 2021
The psychological impact of the COVID-19 pandemic on adults and children in the United Arab Emirates: a nationwide cross-sectional studyBasema Saddik, Amal Hussein, Ammar Albanna, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 27, 2022
Association between previous and future antipsychotic adherence in patients initiating clozapine: real-world observational studySébastien Brodeur, Josiane Courteau, Alain Vanasse, et al.
Clinical Schizophrenia & Related Psychoses|June 19, 2013
An Exploratory, Open-Label, Randomized Trial Comparing Risperidone Long-Acting Injectable with Oral Antipsychotic Medication in the Treatment of Early PsychosisAshok Malla, Pierre Chue, Gerald Jordan, et al.
Pageof 28

Showing results (251-260 of 278) with videos related to

Sort By:
Pageof 28
Neuroimage|August 5, 2015
Impact of the resolution of brain parcels on connectome-wide association studies in fMRIPierre Bellec, Yassine Benhajali, Felix Carbonell, et al.
Current Medical Research and Opinion|July 13, 2006
Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trialStéphane Potvin, Emmanuel Stip, Olivier Lipp, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|October 25, 2022
Frequency of illness anxiety (hypochondriasis) by proxy encountered by doctors in parents towards their childrenDina Aly El-Gabry, Karim Abdel Aziz, Maitha Hasan Al-Hosani, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 2020
Chronic Neuroleptic-Induced Parkinsonism Examined With Positron Emission TomographyManon Galoppin, Pierre Berroir, Jean-Paul Soucy, et al.
Journal of Psychopharmacology (Oxford, England)|March 1, 2008
Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapyStéphane Potvin, Edouard Kouassi, Olivier Lipp, et al.
Journal of Clinical Psychopharmacology|August 16, 2003
A Canadian multicenter trial assessing memory and executive functions in patients with schizophrenia spectrum disorders treated with olanzapineEmmanuel Stip, Gary J Remington, Serdar M Dursun, et al.
Pharmacology, Biochemistry, and Behavior|April 3, 2022
Cannabidiol effects on cognition in individuals with cocaine use disorder: Exploratory results from a randomized controlled trialElie Rizkallah, Violaine Mongeau-Pérusse, Léonardo Lamanuzzi, et al.
BMC Psychiatry|May 4, 2021
The psychological impact of the COVID-19 pandemic on adults and children in the United Arab Emirates: a nationwide cross-sectional studyBasema Saddik, Amal Hussein, Ammar Albanna, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 27, 2022
Association between previous and future antipsychotic adherence in patients initiating clozapine: real-world observational studySébastien Brodeur, Josiane Courteau, Alain Vanasse, et al.
Clinical Schizophrenia & Related Psychoses|June 19, 2013
An Exploratory, Open-Label, Randomized Trial Comparing Risperidone Long-Acting Injectable with Oral Antipsychotic Medication in the Treatment of Early PsychosisAshok Malla, Pierre Chue, Gerald Jordan, et al.
Pageof 28